Mylan sues generic rival Teva over ‘sophisticated scheme’ to block Copaxone copycats fkansteiner Thu, 07/01/2021 – 10:28 More: Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats Source: fierce
read moreCatalyst, Zogenix, Rigel and Pfizer kick off pharma’s July price hikes: report nhigginsdunn Thu, 07/01/2021 – 10:26 More: Catalyst, Zogenix, Rigel and Pfizer kick off pharma's July price hikes: report Source: fierce
read moreJazz clinches Rylaze green light in 2 blood cancers, including the most common cancer among children fkansteiner Thu, 07/01/2021 – 09:47 More: Jazz clinches Rylaze green light in 2 blood cancers, including the most common cancer among children Source: fierce
read moreElliott fires opening salvo at GlaxoSmithKline, calling for new management to fix ‘severe underperformance’ aliu Thu, 07/01/2021 – 08:17 More: Elliott fires opening salvo at GlaxoSmithKline, calling for new management to fix 'severe underperformance' Source: fierce
read moreModerna taps Ogilvy for first chief brand officer as marketing plans await full FDA approval bbulik Thu, 07/01/2021 – 07:44 More: Moderna taps Ogilvy for first chief brand officer as marketing plans await full FDA approval Source: fierce
read moreJAK inhibitor hit primary endpoint of improved clinical remission at 52 weeks in maintenance study More: Rinvoq scores positive results as a maintenance therapy for ulcerative colitis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals